首页> 外文期刊>Stem cell research >MicroRNA-4739 regulates osteogenic and adipocytic differentiation of immortalized human bone marrow stromal cells via targeting LRP3 - ScienceDirect
【24h】

MicroRNA-4739 regulates osteogenic and adipocytic differentiation of immortalized human bone marrow stromal cells via targeting LRP3 - ScienceDirect

机译:MicroRNA-4739通过靶向LRP3调节永生化的人骨髓基质细胞的成骨和脂肪细胞分化-ScienceDirect

获取原文
获取外文期刊封面目录资料

摘要

Understanding the regulatory networks underlying lineage differentiation and fate determination of human bone marrow stromal cells (hBMSC) is a prerequisite for their therapeutic use. The goal of the current study was to unravel the novel role of the low-density lipoprotein receptor-related protein 3 (LRP3) in regulating the osteogenic and adipogenic differentiation of immortalized hBMSCs. Gene expression profiling revealed significantly higher LRP3 levels in the highly osteogenic hBMSC clone imCL1 than in the less osteogenic clone imCL2, as well as a significant upregulation of LRP3 during the osteogenic induction of the imCL1 clone. Data from functional and gene expression assays demonstrated the role of LRP3 as a molecular switch promoting hBMSC lineage differentiation into osteoblasts and inhibiting differentiation into adipocytes. Interestingly, microRNA (miRNA) expression profiling identified miR-4739 as the most under-represented miRNA (??36.11 fold) in imCL1 compared to imCL2. The TargetScan prediction algorithm, combined with functional and biochemical assays, identified LRP3 mRNA as a novel target of miR-4739, with a single potential binding site for miR-4739 located in the LRP3 3′ UTR. Regulation of LRP3 expression by miR-4739 was subsequently confirmed by qRT-PCR, western blotting, and luciferase assays. Over-expression of miR-4739 mimicked the effects of LRP3 knockdown on promoting adipogenic and suppressing osteogenic differentiation of hBMSCs. Hence, we report for the first time a novel biological role for the LRP3/hsa-miR-4739 axis in balancing osteogenic and adipocytic differentiation of hBMSCs. Our data support the potential utilization of miRNA-based therapies in regenerative medicine.
机译:了解人类骨髓基质细胞(hBMSC)沿袭分化和命运决定的调控网络是其治疗用途的前提。本研究的目的是揭示低密度脂蛋白受体相关蛋白3(LRP3)在调节永生化hBMSC的成骨和成脂分化中的新作用。基因表达谱分析显示,成骨性高的hBMSC克隆imCL1中的LRP3水平明显高于成骨性较弱的克隆imCL2中的LRP3水平,以及在成骨诱导imCL1克隆过程中LRP3的显着上调。来自功能和基因表达测定的数据证明了LRP3作为促进hBMSC谱系分化为成骨细胞并抑制分化为脂肪细胞的分子开关的作用。有趣的是,与imCL2相比,microRNA(miRNA)表达谱将miR-4739确定为imCL1中代表性最弱的miRNA(Δ36.11倍)。 TargetScan预测算法与功能和生化分析相结合,确定LRP3 mRNA为miR-4739的新靶标,并且miR-4739的单个潜在结合位点位于LRP3 3'UTR中。 miR-4739对LRP3表达的调节随后通过qRT-PCR,western blotting和荧光素酶试验得以证实。 miR-4739的过表达模拟了LRP3敲低对促进hBMSCs成脂和抑制成骨分化的影响。因此,我们首次报告了LRP3 / hsa-miR-4739轴在平衡hBMSC的成骨和脂肪细胞分化中的新生物学作用。我们的数据支持基于miRNA的疗法在再生医学中的潜在利用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号